Invasive Ductal Breast Carcinoma Completed Phase 2 / 3 Trials for Doxorubicin (DB00997)

Also known as: Invasive Ductal Breast Cancer / Carcinoma, Ductal, Breast / Infiltrating ductular carcinoma / Breast ductal cancer invasive / Breast ductal cancer infiltrating / Infiltrating ductal breast cancer

IndicationStatusPhase
DBCOND0047004 (Invasive Ductal Breast Carcinoma)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01426880Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast CancerTreatment